Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

liver cancer neoantigens-sensitized autoimmune cells IPM001

A preparation of autoimmune cells that have been sensitized to liver cancer neoantigens, with potential immunostimulating and antineoplastic activities, Upon administration of the liver cancer neoantigens-sensitized autoimmune cells IPM001, these cells may eradicate the liver cancer cells.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Code name:	IPM 001 IPM-001 IPM001

liver cancer neoantigens-sensitized autoimmune cells IPM001

Search NCI's Drug Dictionary